Horizon Pharma plc (HZNP)

24.92
NASDAQ
Prev Close 24.92
Day Low/High 0.00 / 0.00
52 Wk Low/High 12.55 / 29.44
Exchange NASDAQ
Shares Outstanding 184.52B
Market Cap 4.60B
Div & Yield N.A. (N.A)
HORIZON PHARMA Plc SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Horizon Pharma Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

HORIZON PHARMA Plc SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Horizon Pharma Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Class Action Involving Horizon Pharma Plc And A Lead Plaintiff Deadline Of May 9, 2016

INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Class Action Involving Horizon Pharma Plc And A Lead Plaintiff Deadline Of May 9, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Horizon Pharma plc (NASDAQ: HZNP) securities...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Horizon Pharma Plc Of Class Action Lawsuit And A Lead Plaintiff Deadline Of May 9, 2016 - HZNP

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Horizon Pharma Plc Of Class Action Lawsuit And A Lead Plaintiff Deadline Of May 9, 2016 - HZNP

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Horizon Pharma plc ("Horizon" or the "Company") (Nasdaq:HZNP)...

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Horizon Pharma Plc Investors And Encourages Investors To Contact The Firm

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Horizon Pharma Plc Investors And Encourages Investors To Contact The Firm

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Horizon Pharma plc ("Horizon Pharma" or the "Company") (NYSE: HZNP) securities between...

HZNP INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Horizon Pharma PLC

HZNP INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Horizon Pharma PLC

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of investors who purchased or otherwise acquired the securities of Horizon Pharma PLC ("Horizon"...

INVESTOR ALERT: The Law Offices Of Vincent Wong Remind Investors Of Class Action Involving Horizon Pharma Plc And A Lead Plaintiff Deadline Of May 9, 2016

INVESTOR ALERT: The Law Offices Of Vincent Wong Remind Investors Of Class Action Involving Horizon Pharma Plc And A Lead Plaintiff Deadline Of May 9, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District District of New York on behalf of investors who purchased Horizon Pharma plc (NASDAQ: HZNP)...

STOCK ALERT: Rosen Law Firm Reminds Horizon Pharma Plc Investors Of Important Deadline In Class Action - HZNP

STOCK ALERT: Rosen Law Firm Reminds Horizon Pharma Plc Investors Of Important Deadline In Class Action - HZNP

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Horizon Pharma plc securities (NASDAQ:HZNP) from March 13, 2014 through February 26, 2016, all dates inclusive (the "Class Period") of the important...

Horizon Pharma (HZNP) Is Today's Strong On High Volume Stock

Horizon Pharma (HZNP) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a strong on high relative volume candidate

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Horizon Pharma Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Horizon Pharma Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

Glancy, Prongay & Murray Announces The Filing Of A Securities Class Action On Behalf Of Horizon Pharma Plc Investors And Encourages Investors To Contact The Firm

Glancy, Prongay & Murray Announces The Filing Of A Securities Class Action On Behalf Of Horizon Pharma Plc Investors And Encourages Investors To Contact The Firm

Glancy Prongay & Murray ("GPM") announces that a class action lawsuit has been filed on behalf of investors who purchased Horizon Pharma plc ("Horizon Pharma" or the "Company") (NYSE: HZNP) securities...

Horizon Pharma (HZNP) Highlighted As Weak On High Volume

Horizon Pharma (HZNP) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a weak on high relative volume candidate

Strong On High Relative Volume: Horizon Pharma (HZNP)

Strong On High Relative Volume: Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a strong on high relative volume candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BIG, BNCL, CINR, FLML, GOOD, HZNP, INS, KATE, MRVL, NCLH, NRCIA, RMBS, ROK, TECH, VAC Downgrades: AIQ, CRD.B, GHC, HRB, IFON, NNBR Initiations: AVNU, PRQR Read on to get TheStreet Quant Ratings' detailed report:

INVESTOR ALERT: Khang & Khang LLP Announces An Investigation Of Claims Against Horizon Pharma Plc And Strongly Encourages Investors To Contact The Firm

INVESTOR ALERT: Khang & Khang LLP Announces An Investigation Of Claims Against Horizon Pharma Plc And Strongly Encourages Investors To Contact The Firm

Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Horizon Pharma plc ("Horizon" or the "Company") (Nasdaq: HZNP).

IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces An Investigation Of Claims Against Horizon Pharma Plc And Strongly Encourages Investors To Contact The Firm

IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces An Investigation Of Claims Against Horizon Pharma Plc And Strongly Encourages Investors To Contact The Firm

Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Horizon Pharma plc ("Horizon" or the "Company") (Nasdaq: HZNP).

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Horizon Pharma Plc - HZNP

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Horizon Pharma Plc - HZNP

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Horizon Pharma plc securities (NASDAQ:HZNP) from March 13, 2014 through February 26, 2016, all...

Trade-Ideas: Horizon Pharma (HZNP) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Horizon Pharma (HZNP) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a strong on high relative volume candidate

Jim Cramer Recommends Ford Over General Motors Among Autos

Jim Cramer Recommends Ford Over General Motors Among Autos

Automakers are reporting sales results today, and Ford is Jim Cramer’s top pick in the auto sector.

Insider Trading Alert - BRT, TNAV And HZNP Traded By Insiders

Insider Trading Alert - BRT, TNAV And HZNP Traded By Insiders

Stocks with insider trader activity include BRT, TNAV and HZNP

Silly Season Continues for Biotech

Silly Season Continues for Biotech

Valuations of some small-cap concerns, such as Relypsa, are ridiculously cheap.

3 Stocks Trading on Big Volume -- and What to Do With Them Now

3 Stocks Trading on Big Volume -- and What to Do With Them Now

Here's a technical look at how to trade some of the most active stocks on the market right now.

Will Horizon Pharma (HZNP) Stock Be Helped By Earnings Beat?

Will Horizon Pharma (HZNP) Stock Be Helped By Earnings Beat?

Horizon Pharma (HZNP) reported better-than-expected 2015 fourth quarter results before the market open on Monday.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Horizon Pharma Plc And Certain Officers And Directors

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Horizon Pharma Plc And Certain Officers And Directors

Levi & Korsinsky, LLP announces that it has commenced an investigation of Horizon Pharma plc ("Horizon Pharma" or the "Company") (NASDAQGS:HZNP) concerning possible violations of federal securities laws by the Company...

Horizon Pharma (HZNP) In A Perilous Reversal

Horizon Pharma (HZNP) In A Perilous Reversal

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

With Martin Shkreli Long Gone, Retrophin is an 'Interesting Opportunity'

With Martin Shkreli Long Gone, Retrophin is an 'Interesting Opportunity'

Retrophin (RTRX), the biotech company that used to be run by indicted hedge fund manager Martin Shkreki, provides an interesting investment opportunity.

Despite Shkreli Drama, Retrophin Looks Interesting Now

Despite Shkreli Drama, Retrophin Looks Interesting Now

One biotech portfolio manager thinks Retrophin, the biotech company once run by indicted hedge fund manager Martin Shkreli, could be a promising investment.

Today's Weak On High Volume Stock: Horizon Pharma (HZNP)

Today's Weak On High Volume Stock: Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a weak on high relative volume candidate

Stock To Watch: Horizon Pharma (HZNP) In Perilous Reversal

Stock To Watch: Horizon Pharma (HZNP) In Perilous Reversal

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

Horizon Pharma (HZNP) Stock Gains on Raised Guidance

Horizon Pharma (HZNP) Stock Gains on Raised Guidance

Horizon Pharma (HZNP) stock is increasing in mid-morning trading on Tuesday after the company raised its full-year 2016 revenue guidance.

TheStreet Quant Rating: B- (Buy)